BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE

BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE was reported 3071 times

BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 CHONDROLYSIS 119 0.2532
1 AMNIOTIC FLUID EMBOLUS 2 0.2222
2 BLADDER TRANSITIONAL CELL CARCINOMA STAGE 0 2 0.0769
3 CHONDROMALACIA 11 0.0386
4 ANAESTHETIC COMPLICATION 103 0.0383
5 CAUDA EQUINA SYNDROME 28 0.0365
6 INCISION SITE RASH 2 0.0333
7 THERAPEUTIC RESPONSE PROLONGED 3 0.0319
8 ANAESTHETIC COMPLICATION CARDIAC 2 0.0290
9 INJECTION SITE ISCHAEMIA 2 0.0278
10 NERVE ROOT INJURY 2 0.0263
11 NERVE ROOT LESION 2 0.0250
12 SCIATIC NERVE PALSY 2 0.0244
13 ARTHROFIBROSIS 2 0.0196
14 JAW CLICKING 4 0.0188
15 SPLENIC GRANULOMA 2 0.0187
16 URINARY RETENTION POSTOPERATIVE 3 0.0182
17 CSF GLUCOSE DECREASED 2 0.0172
18 PANCREATIC ENZYMES DECREASED 2 0.0156
19 WOUND NECROSIS 7 0.0146
20 PH BODY FLUID ABNORMAL 2 0.0144
21 LOCAL ANAESTHETIC SYSTEMIC TOXICITY 14 0.0132
22 BLOOD PRESSURE ORTHOSTATIC 2 0.0126
23 LUMBOSACRAL RADICULOPATHY 2 0.0124
24 PERIPARTUM CARDIOMYOPATHY 2 0.0116
25 KYPHOSCOLIOSIS 3 0.0114
26 DEAFNESS PERMANENT 2 0.0102
27 IMPLANT SITE MASS 2 0.0102
28 ARACHNOIDITIS 7 0.0101
29 TOXIC ANTERIOR SEGMENT SYNDROME 11 0.0101
30 JOINT LAXITY 3 0.0099
31 SUSPECTED PRODUCT CONTAMINATION 10 0.0099
32 UNWANTED AWARENESS DURING ANAESTHESIA 3 0.0091
33 DRUG EFFECT PROLONGED 5 0.0091
34 ACUTE STRESS DISORDER 3 0.0090
35 OPERATIVE HAEMORRHAGE 4 0.0089
36 NECROTISING SOFT TISSUE INFECTION 2 0.0087
37 MYOFASCIAL PAIN SYNDROME 6 0.0084
38 CALCIUM IONISED DECREASED 2 0.0082
39 MICROCYTOSIS 2 0.0081
40 SUSPECTED TRANSMISSION OF AN INFECTIOUS AGENT VIA PRODUCT 10 0.0080
41 DRUG LABEL CONFUSION 2 0.0080
42 BREATH HOLDING 3 0.0078
43 JOINT RANGE OF MOTION DECREASED 98 0.0073
44 NERVE BLOCK 4 0.0068
45 DEVICE COMPUTER ISSUE 2 0.0067
46 GENERAL ANAESTHESIA 3 0.0067
47 INCISION SITE SWELLING 2 0.0066
48 JOINT INJURY 135 0.0063
49 LOSS OF PROPRIOCEPTION 2 0.0062
50 MATERNAL EXPOSURE DURING DELIVERY 6 0.0061
51 SENSORIMOTOR DISORDER 3 0.0060
52 PRODUCT MEASURED POTENCY ISSUE 6 0.0060
53 COMPLICATIONS OF MATERNAL EXPOSURE TO THERAPEUTIC DRUGS 4 0.0059
54 JOINT ABSCESS 2 0.0057
55 DRUG EFFECT DELAYED 25 0.0055
56 APGAR SCORE LOW 7 0.0054
57 NEUROMUSCULAR BLOCK PROLONGED 2 0.0054
58 PANCREATIC ENLARGEMENT 2 0.0054
59 BONE CYST 5 0.0053
60 SCROTAL ABSCESS 2 0.0053
61 PERIPROSTHETIC FRACTURE 2 0.0053
62 ARTHRITIS INFECTIVE 24 0.0052
63 ANKYLOGLOSSIA CONGENITAL 2 0.0050
64 HYPOGLYCAEMIA NEONATAL 8 0.0049
65 ARTHRITIS BACTERIAL 20 0.0049
66 POST LUMBAR PUNCTURE SYNDROME 5 0.0048
67 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 42 0.0047
68 SURGICAL PROCEDURE REPEATED 3 0.0044
69 DIPLEGIA 8 0.0040
70 INJECTION SITE ABSCESS 10 0.0040
71 DEBRIDEMENT 3 0.0039
72 MUSCULOSKELETAL PAIN 203 0.0039
73 DEVICE DAMAGE 3 0.0038
74 CORYNEBACTERIUM INFECTION 2 0.0037
75 SOMATIC SYMPTOM DISORDER 4 0.0037
76 HYPOPYON 3 0.0036
77 BLOOD PH INCREASED 2 0.0036
78 PROCEDURAL HYPOTENSION 3 0.0035
79 PO2 DECREASED 4 0.0035
80 PARAPLEGIA 10 0.0035
81 STAPHYLOCOCCUS TEST POSITIVE 7 0.0033
82 MUSCULOSKELETAL DISCOMFORT 56 0.0033
83 SKIN TEST POSITIVE 3 0.0032
84 FOETAL HEART RATE DECREASED 2 0.0032
85 SLEEP-RELATED EATING DISORDER 3 0.0032
86 HYPERPARATHYROIDISM SECONDARY 8 0.0032
87 DELAYED RECOVERY FROM ANAESTHESIA 3 0.0032
88 DEVICE BATTERY ISSUE 2 0.0030
89 DELIVERY 2 0.0030
90 EXTRADURAL HAEMATOMA 4 0.0030
91 GAZE PALSY 5 0.0029
92 BLOOD PH DECREASED 5 0.0029
93 CONJUNCTIVAL OEDEMA 3 0.0029
94 BONE MARROW OEDEMA 3 0.0029
95 MENISCUS LESION 4 0.0029
96 FOREARM FRACTURE 2 0.0029
97 THERAPEUTIC PRODUCT EFFECT DELAYED 13 0.0028
98 CARTILAGE INJURY 7 0.0028
99 TONIC CONVULSION 4 0.0028
100 DEVICE INFUSION ISSUE 7 0.0028
101 CERVICAL RADICULOPATHY 2 0.0028
102 EXOPHTHALMOS 6 0.0028
103 CALCULUS URETERIC 2 0.0028
104 ESCHAR 2 0.0027
105 ATROPHIC VULVOVAGINITIS 2 0.0027
106 SERRATIA INFECTION 2 0.0027
107 BRAIN STEM SYNDROME 2 0.0027
108 CATHETER RELATED COMPLICATION 3 0.0027
109 PERIARTHRITIS 6 0.0026
110 SICK SINUS SYNDROME 3 0.0026
111 CARBON DIOXIDE DECREASED 3 0.0026
112 CHONDROCALCINOSIS PYROPHOSPHATE 2 0.0026
113 CHONDROPATHY 7 0.0026
114 ALLODYNIA 3 0.0026
115 INCISION SITE PAIN 3 0.0026
116 IMPLANT SITE EXTRAVASATION 2 0.0025
117 NEONATAL DISORDER 4 0.0025
118 JOINT CREPITATION 5 0.0025
119 PROCEDURAL NAUSEA 2 0.0025
120 CYSTITIS INTERSTITIAL 4 0.0025
121 REACTION TO PRESERVATIVES 2 0.0025
122 NEONATAL HYPOXIA 2 0.0024
123 BRADYCARDIA FOETAL 2 0.0024
124 BRADYCARDIA NEONATAL 3 0.0024
125 STRABISMUS 7 0.0024
126 NEPHROGENIC ANAEMIA 11 0.0024
127 MONOPLEGIA 10 0.0023
128 RADICULOPATHY 6 0.0023
129 HILAR LYMPHADENOPATHY 2 0.0023
130 ANGIONEUROTIC OEDEMA 6 0.0022
131 ANION GAP INCREASED 3 0.0022
132 INFUSION SITE RASH 3 0.0022
133 PRODUCT APPEARANCE CONFUSION 2 0.0022
134 CEREBROSPINAL FLUID LEAKAGE 4 0.0022
135 POOR QUALITY DRUG ADMINISTERED 14 0.0022
136 ADENOCARCINOMA GASTRIC 2 0.0022
137 PHARYNGEAL HYPOAESTHESIA 2 0.0022
138 BONE GRAFT 2 0.0021
139 INJECTION SITE INFECTION 7 0.0021
140 DEAFNESS NEUROSENSORY 7 0.0021
141 PULPITIS DENTAL 2 0.0021
142 BLOOD ALKALINE PHOSPHATASE DECREASED 2 0.0021
143 MENINGITIS BACTERIAL 3 0.0021
144 ACTINOMYCOSIS 2 0.0021
145 PROCEDURAL COMPLICATION 16 0.0021
146 SUBCUTANEOUS EMPHYSEMA 2 0.0020
147 HYPERTHERMIA MALIGNANT 3 0.0020
148 THROMBOPHLEBITIS SUPERFICIAL 6 0.0020
149 BLOOD PRESSURE IMMEASURABLE 3 0.0020
150 MEAN CELL VOLUME DECREASED 3 0.0019
151 RETINAL TOXICITY 2 0.0019
152 QUADRIPLEGIA 4 0.0019
153 INTRACRANIAL VENOUS SINUS THROMBOSIS 2 0.0019
154 GALLBLADDER ENLARGEMENT 2 0.0019
155 IRON OVERLOAD 2 0.0019
156 ARRHYTHMIA SUPRAVENTRICULAR 2 0.0018
157 DRUG EXPOSURE VIA BREAST MILK 2 0.0018
158 INJECTION RELATED REACTION 3 0.0018
159 SOFT TISSUE DISORDER 2 0.0018
160 NEPHROSCLEROSIS 2 0.0018
161 ROTATOR CUFF SYNDROME 23 0.0018
162 CORNEAL OEDEMA 4 0.0018
163 INADEQUATE ANALGESIA 15 0.0018
164 PULMONARY GRANULOMA 2 0.0018
165 BLOOD FIBRINOGEN DECREASED 2 0.0018
166 BLOOD CHLORIDE INCREASED 3 0.0017
167 SKIN NECROSIS 9 0.0017
168 LUMBAR RADICULOPATHY 2 0.0017
169 OPTIC NERVE INJURY 2 0.0017
170 MENINGITIS 11 0.0016
171 ESSENTIAL HYPERTENSION 3 0.0016
172 CAESAREAN SECTION 19 0.0016
173 INJECTION SITE INFLAMMATION 8 0.0016
174 SEROMA 2 0.0016
175 IATROGENIC INJURY 2 0.0016
176 PRODUCT LABEL CONFUSION 9 0.0015
177 DRUG EFFECT INCOMPLETE 56 0.0015
178 MUSCULOSKELETAL DISORDER 29 0.0015
179 ANORECTAL DISORDER 3 0.0015
180 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 4 0.0015
181 SHOULDER ARTHROPLASTY 4 0.0015
182 CLONUS 4 0.0015
183 FOETAL DISTRESS SYNDROME 3 0.0014
184 SEBORRHOEIC KERATOSIS 2 0.0014
185 HYPOTHALAMO-PITUITARY DISORDER 2 0.0014
186 GENERALISED ANXIETY DISORDER 2 0.0014
187 PHYSICAL DISABILITY 6 0.0014
188 COMPLEX REGIONAL PAIN SYNDROME 2 0.0014
189 PARESIS 3 0.0013
190 CHOLECYSTITIS CHRONIC 9 0.0013
191 EPICONDYLITIS 2 0.0013
192 ADHESION 2 0.0013
193 NEURITIS 2 0.0013
194 THERAPEUTIC PRODUCT INEFFECTIVE 5 0.0013
195 ORAL MUCOSAL ERYTHEMA 2 0.0013
196 MYELITIS 2 0.0013
197 APNOEA 10 0.0013
198 HYPOTONIA NEONATAL 2 0.0013
199 OSTEOSCLEROSIS 2 0.0013
200 PULSE ABSENT 6 0.0013
201 STREPTOCOCCAL INFECTION 7 0.0013
202 SENSORY DISTURBANCE 20 0.0012
203 RESPIRATORY DISORDER NEONATAL 2 0.0012
204 NO THERAPEUTIC RESPONSE 15 0.0012
205 DERMAL CYST 3 0.0012
206 MEDICAL DEVICE COMPLICATION 9 0.0012
207 BRADYARRHYTHMIA 2 0.0012
208 INJECTION SITE ATROPHY 2 0.0012
209 SPINAL CORD DISORDER 2 0.0012
210 RESUSCITATION 2 0.0012
211 POST PROCEDURAL COMPLICATION 23 0.0012
212 RECTAL ABSCESS 2 0.0012
213 POST PROCEDURAL HAEMATOMA 2 0.0012
214 SEIZURE LIKE PHENOMENA 2 0.0012
215 ANGLE CLOSURE GLAUCOMA 3 0.0012
216 MATERNAL DRUGS AFFECTING FOETUS 9 0.0012
217 DIFFICULTY IN WALKING 4 0.0012
218 PUPIL FIXED 2 0.0012
219 STATUS EPILEPTICUS 13 0.0011
220 SPINAL CORD INJURY 2 0.0011
221 NECROTISING FASCIITIS 4 0.0011
222 GASTROINTESTINAL OEDEMA 2 0.0011
223 PARAPARESIS 2 0.0011
224 WEIGHT BEARING DIFFICULTY 3 0.0011
225 BLOOD SODIUM INCREASED 3 0.0011
226 BONE LESION 4 0.0011
227 DEVICE ALARM ISSUE 2 0.0011
228 HYPERAESTHESIA 9 0.0011
229 BLOOD PHOSPHORUS DECREASED 4 0.0011
230 SYNOVIAL CYST 5 0.0011
231 MYELOPATHY 2 0.0011
232 PRODUCT LABEL ISSUE 7 0.0010
233 ATROPHY 2 0.0010
234 SPINAL OSTEOARTHRITIS 9 0.0010
235 ARTERIOSPASM CORONARY 4 0.0010
236 HYPERCAPNIA 3 0.0010
237 SENSORY LOSS 8 0.0010
238 OSTEOARTHRITIS 42 0.0010
239 BURSITIS 12 0.0010
240 EXOSTOSIS 9 0.0010
241 INJECTION SITE NECROSIS 2 0.0010
242 MOTOR DYSFUNCTION 10 0.0010
243 FIBROSIS 3 0.0010
244 BRAIN DEATH 3 0.0010
245 STAPHYLOCOCCAL INFECTION 32 0.0010
246 ANAPHYLACTIC SHOCK 25 0.0010
247 BLOOD CREATININE DECREASED 3 0.0010
248 SLEEP DEFICIT 2 0.0009
249 BUNDLE BRANCH BLOCK LEFT 4 0.0009
250 HYPERPHOSPHATAEMIA 2 0.0009
251 EXPOSED BONE IN JAW 2 0.0009
252 HYDROCEPHALUS 5 0.0009
253 ELECTROCARDIOGRAM ST SEGMENT DEPRESSION 2 0.0009
254 PARALYSIS 13 0.0009
255 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 3 0.0009
256 LIGAMENT RUPTURE 4 0.0009
257 RHINITIS ALLERGIC 4 0.0009
258 FEAR OF DEATH 2 0.0009
259 WOUND DEHISCENCE 3 0.0009
260 HEPATOCELLULAR DAMAGE 2 0.0009
261 SUSPECTED OFF LABEL USE 4 0.0009
262 BLOOD THYROID STIMULATING HORMONE DECREASED 4 0.0009
263 ECCHYMOSIS 6 0.0009
264 DRUG EFFECT DECREASED 47 0.0009
265 EYELID DISORDER 2 0.0009
266 GRANULOMA 3 0.0009
267 FLAT AFFECT 2 0.0009
268 IMPLANT SITE INFECTION 2 0.0009
269 THROMBOPHLEBITIS 3 0.0009
270 DISSEMINATED INTRAVASCULAR COAGULATION 12 0.0009
271 PULMONARY INFARCTION 2 0.0008
272 PRODUCT CONTAMINATION 3 0.0008
273 FRUSTRATION 3 0.0008
274 DRUG INEFFECTIVE 1101 0.0008
275 RASH VESICULAR 4 0.0008
276 LYMPHADENITIS 2 0.0008
277 END STAGE RENAL DISEASE 15 0.0008
278 NERVE INJURY 9 0.0008
279 DIABETIC NEUROPATHY 4 0.0008
280 BLOOD CALCIUM DECREASED 9 0.0008
281 NEUROTOXICITY 14 0.0008
282 PROTEIN TOTAL DECREASED 3 0.0008
283 RETINAL ARTERY OCCLUSION 2 0.0008
284 FACE INJURY 3 0.0008
285 EXCORIATION 2 0.0008
286 INCREASED BRONCHIAL SECRETION 2 0.0008
287 AORTIC ARTERIOSCLEROSIS 2 0.0008
288 BLOOD CHLORIDE DECREASED 2 0.0008
289 SPINAL CORD COMPRESSION 3 0.0008
290 COMPARTMENT SYNDROME 2 0.0008
291 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 2 0.0008
292 WALKING AID USER 5 0.0008
293 MIOSIS 6 0.0007
294 MOVEMENT DISORDER 24 0.0007
295 LACERATION 7 0.0007
296 INJECTION SITE DISCHARGE 4 0.0007
297 LARYNGOSPASM 2 0.0007
298 NORMAL NEWBORN 4 0.0007
299 TRIGGER FINGER 3 0.0007
300 DRUG TOXICITY 10 0.0007
301 PHARMACEUTICAL PRODUCT COMPLAINT 19 0.0007
302 ECONOMIC PROBLEM 11 0.0007
303 ATELECTASIS 7 0.0007
304 DEVICE FAILURE 11 0.0007
305 PULSELESS ELECTRICAL ACTIVITY 3 0.0007
306 CARDIAC ARREST 59 0.0007
307 ACTIVITIES OF DAILY LIVING IMPAIRED 14 0.0007
308 ACUTE LYMPHOCYTIC LEUKAEMIA 2 0.0007
309 DRUG EXPOSURE DURING PREGNANCY 24 0.0007
310 PERONEAL NERVE PALSY 4 0.0007
311 CYANOSIS 11 0.0007
312 DEVICE POWER SOURCE ISSUE 2 0.0007
313 AUTONOMIC NERVOUS SYSTEM IMBALANCE 2 0.0007
314 ONYCHOMYCOSIS 3 0.0007
315 STRIDOR 2 0.0007
316 IMPLANT SITE PAIN 3 0.0007
317 ANAPHYLACTIC REACTION 37 0.0007
318 KERATITIS 2 0.0007
319 BOWEL MOVEMENT IRREGULARITY 5 0.0007
320 DYSAESTHESIA 2 0.0007
321 MUSCLE SPASTICITY 8 0.0007
322 PROCEDURAL PAIN 18 0.0006
323 INTERVERTEBRAL DISC DEGENERATION 6 0.0006
324 CONCOMITANT DISEASE AGGRAVATED 4 0.0006
325 DIASTOLIC DYSFUNCTION 2 0.0006
326 RESPIRATORY RATE DECREASED 2 0.0006
327 MULTIPLE INJURIES 4 0.0006
328 SPINAL COLUMN STENOSIS 3 0.0006
329 BLADDER PAIN 2 0.0006
330 BILE DUCT STONE 2 0.0006
331 ABSCESS 10 0.0006
332 KIDNEY TRANSPLANT REJECTION 3 0.0006
333 PORTAL VEIN THROMBOSIS 2 0.0006
334 TENDON DISORDER 4 0.0006
335 INCORRECT PRODUCT STORAGE 8 0.0006
336 DRUG EFFECT LESS THAN EXPECTED 9 0.0006
337 HYPERVOLAEMIA 3 0.0006
338 PRODUCT FORMULATION ISSUE 4 0.0006
339 VENTRICULAR TACHYCARDIA 10 0.0006
340 EYELID OEDEMA 7 0.0006
341 HIGH DENSITY LIPOPROTEIN DECREASED 2 0.0006
342 VEIN DISORDER 3 0.0006
343 BRAIN INJURY 6 0.0006
344 HYPOAESTHESIA ORAL 9 0.0006
345 POST-TRAUMATIC STRESS DISORDER 4 0.0006
346 CORONARY ARTERY STENOSIS 3 0.0006
347 PATHOLOGICAL FRACTURE 3 0.0006
348 CIRCULATORY COLLAPSE 10 0.0006
349 FEMORAL NECK FRACTURE 3 0.0006
350 BRADYCARDIA 31 0.0006
351 SCAR 10 0.0006
352 UNRESPONSIVE TO STIMULI 15 0.0006
353 JOINT EFFUSION 4 0.0006
354 ENCEPHALITIS 4 0.0006
355 VENTRICULAR EXTRASYSTOLES 6 0.0006
356 HYPOPNOEA 2 0.0006
357 SERUM FERRITIN INCREASED 3 0.0006
358 HYPOXIA 20 0.0006
359 HAEMORRHAGE SUBCUTANEOUS 2 0.0006
360 WRONG DRUG ADMINISTERED 5 0.0006
361 CONVULSION 32 0.0006
362 CARDIOGENIC SHOCK 8 0.0006
363 INJURY 39 0.0006
364 SYNOVITIS 10 0.0006
365 DEVICE KINK 2 0.0005
366 DENTAL CARIES 6 0.0005
367 URINARY INCONTINENCE 16 0.0005
368 DIPLOPIA 14 0.0005
369 THERAPEUTIC PRODUCT EFFECT DECREASED 24 0.0005
370 HYPOAESTHESIA 80 0.0005
371 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 4 0.0005
372 MITRAL VALVE INCOMPETENCE 6 0.0005
373 AUTOIMMUNE THYROIDITIS 2 0.0005
374 SNORING 2 0.0005
375 LOSS OF CONTROL OF LEGS 2 0.0005
376 GENERALISED ERYTHEMA 3 0.0005
377 SUPRAVENTRICULAR TACHYCARDIA 5 0.0005
378 RENAL FAILURE CHRONIC 4 0.0005
379 LOW DENSITY LIPOPROTEIN INCREASED 4 0.0005
380 MUSCLE RUPTURE 2 0.0005
381 BLOOD PRESSURE DECREASED 34 0.0005
382 PROCEDURAL HAEMORRHAGE 2 0.0005
383 COLD SWEAT 9 0.0005
384 BLOOD TRIGLYCERIDES INCREASED 9 0.0005
385 PRODUCT QUALITY ISSUE 69 0.0005
386 TRICUSPID VALVE INCOMPETENCE 4 0.0005
387 ENDOPHTHALMITIS 3 0.0005
388 CARPAL TUNNEL SYNDROME 7 0.0005
389 SKIN REACTION 7 0.0005
390 HYPOTHERMIA 5 0.0005
391 PERIPHERAL ISCHAEMIA 2 0.0005
392 MENISCUS INJURY 3 0.0005
393 EAR DISCOMFORT 5 0.0005
394 IMPAIRED QUALITY OF LIFE 7 0.0005
395 EXTRAVASATION 2 0.0005
396 ANAPHYLACTOID REACTION 2 0.0005
397 BRAIN OEDEMA 6 0.0005
398 RESPIRATORY ARREST 13 0.0005
399 ABSCESS LIMB 2 0.0005
400 PURULENT DISCHARGE 2 0.0005
401 LEFT VENTRICULAR HYPERTROPHY 2 0.0005
402 MUSCLE STRAIN 4 0.0005
403 ATRIOVENTRICULAR BLOCK FIRST DEGREE 2 0.0005
404 STAPHYLOCOCCAL BACTERAEMIA 2 0.0005
405 SOMNAMBULISM 3 0.0005
406 GROIN PAIN 4 0.0005
407 PRESYNCOPE 11 0.0005
408 NEURALGIA 11 0.0005
409 BLOOD CREATINE INCREASED 2 0.0005
410 VENTRICULAR FIBRILLATION 5 0.0004
411 ATRIOVENTRICULAR BLOCK COMPLETE 3 0.0004
412 LEFT VENTRICULAR DYSFUNCTION 3 0.0004
413 MYOSITIS 4 0.0004
414 METASTASES TO LYMPH NODES 3 0.0004
415 DISCOMFORT 27 0.0004
416 MICTURITION URGENCY 5 0.0004
417 DYSPAREUNIA 2 0.0004
418 TINNITUS 20 0.0004
419 ISCHAEMIA 2 0.0004
420 MUSCLE TIGHTNESS 7 0.0004
421 PERFORMANCE STATUS DECREASED 2 0.0004
422 DEFORMITY 4 0.0004
423 SPLENOMEGALY 5 0.0004
424 THERAPEUTIC RESPONSE SHORTENED 14 0.0004
425 PRE-ECLAMPSIA 2 0.0004
426 GESTATIONAL DIABETES 2 0.0004
427 INCORRECT ROUTE OF DRUG ADMINISTRATION 15 0.0004
428 AFFECT LABILITY 4 0.0004
429 HUMERUS FRACTURE 2 0.0004
430 UTERINE LEIOMYOMA 3 0.0004
431 RENAL TUBULAR NECROSIS 4 0.0004
432 HEPARIN-INDUCED THROMBOCYTOPENIA 2 0.0004
433 HYPOTONIA 4 0.0004
434 DEEP VEIN THROMBOSIS 26 0.0004
435 PAROSMIA 3 0.0004
436 EYELID PTOSIS 4 0.0004
437 AMMONIA INCREASED 2 0.0004
438 INTRAOCULAR PRESSURE INCREASED 5 0.0004
439 EUPHORIC MOOD 4 0.0004
440 PHARYNGEAL OEDEMA 6 0.0004
441 URINARY RETENTION 13 0.0004
442 HYPOTENSION 78 0.0004
443 CEREBRAL ISCHAEMIA 2 0.0004
444 ATRIOVENTRICULAR BLOCK 3 0.0004
445 TEMPERATURE INTOLERANCE 4 0.0004
446 TENDONITIS 6 0.0004
447 OSTEOMYELITIS 7 0.0004
448 NERVOUS SYSTEM DISORDER 12 0.0004
449 PULMONARY HAEMORRHAGE 3 0.0004
450 BLOOD LACTIC ACID INCREASED 2 0.0004
451 DRUG SCREEN POSITIVE 3 0.0004
452 BLOOD ALBUMIN DECREASED 3 0.0004
453 DYSSTASIA 11 0.0004
454 PHARYNGOLARYNGEAL PAIN 2 0.0004
455 UTERINE CANCER 3 0.0004
456 FOOD POISONING 2 0.0004
457 COMPRESSION FRACTURE 2 0.0004
458 ANAL ABSCESS 2 0.0004
459 BACK DISORDER 6 0.0004
460 DECUBITUS ULCER 3 0.0004
461 BLINDNESS 15 0.0004
462 TACHYPNOEA 5 0.0004
463 SLEEP APNOEA SYNDROME 7 0.0004
464 JAW DISORDER 2 0.0004
465 DEAFNESS UNILATERAL 2 0.0004
466 HYPERKERATOSIS 2 0.0004
467 ARTHROPATHY 20 0.0004
468 NECROSIS 2 0.0004
469 HEART RATE ABNORMAL 2 0.0004
470 ANGIOPATHY 2 0.0004
471 OXYGEN SATURATION DECREASED 20 0.0004
472 HAEMATOCRIT DECREASED 7 0.0004
473 SINUS TACHYCARDIA 5 0.0004
474 BRONCHOSPASM 5 0.0004
475 NEUROLOGICAL SYMPTOM 2 0.0003
476 HYPERTONIA 2 0.0003
477 BLOOD MAGNESIUM DECREASED 3 0.0003
478 PRODUCT ADMINISTRATION ERROR 7 0.0003
479 METASTASES TO LUNG 4 0.0003
480 HYPERVENTILATION 2 0.0003
481 COMPLICATION ASSOCIATED WITH DEVICE 5 0.0003
482 FEELING OF BODY TEMPERATURE CHANGE 2 0.0003
483 LUNG INFILTRATION 3 0.0003
484 ACUTE RESPIRATORY DISTRESS SYNDROME 6 0.0003
485 CELLULITIS 17 0.0003
486 NEUROLEPTIC MALIGNANT SYNDROME 4 0.0003
487 RENAL INJURY 10 0.0003
488 PROTHROMBIN TIME PROLONGED 2 0.0003
489 SQUAMOUS CELL CARCINOMA OF SKIN 2 0.0003
490 NOCTURIA 4 0.0003
491 RESPIRATORY DEPRESSION 4 0.0003
492 PULMONARY EMBOLISM 31 0.0003
493 RESPIRATORY DISTRESS 9 0.0003
494 CARDIOMEGALY 4 0.0003
495 TENDON RUPTURE 4 0.0003
496 SCOLIOSIS 2 0.0003
497 HEPATIC STEATOSIS 6 0.0003
498 DRUG WITHDRAWAL SYNDROME 28 0.0003
499 CHRONIC KIDNEY DISEASE 24 0.0003
500 MUSCLE ATROPHY 4 0.0003
501 SINUS BRADYCARDIA 3 0.0003
502 BLOOD POTASSIUM INCREASED 5 0.0003
503 HEPATITIS ACUTE 2 0.0003
504 VITAMIN D DEFICIENCY 3 0.0003
505 TACHYCARDIA 27 0.0003
506 DYSGRAPHIA 2 0.0003
507 PULMONARY CONGESTION 4 0.0003
508 LIGAMENT SPRAIN 3 0.0003
509 OVARIAN CYST 3 0.0003
510 BLOOD UREA INCREASED 5 0.0003
511 QUALITY OF LIFE DECREASED 4 0.0003
512 POSTOPERATIVE WOUND INFECTION 2 0.0003
513 CANDIDA INFECTION 5 0.0003
514 SKELETAL INJURY 3 0.0003
515 PARANOIA 5 0.0003
516 EXPOSURE DURING PREGNANCY 18 0.0003
517 LOSS OF CONSCIOUSNESS 37 0.0003
518 EXTRASYSTOLES 2 0.0003
519 MASS 4 0.0003
520 BLISTER 16 0.0003
521 PAIN 175 0.0003
522 HEART RATE DECREASED 10 0.0003
523 ABASIA 7 0.0003
524 DIVERTICULUM 2 0.0003
525 RETINAL HAEMORRHAGE 2 0.0003
526 DECREASED ACTIVITY 3 0.0003
527 SWELLING 26 0.0003
528 ALTERED STATE OF CONSCIOUSNESS 6 0.0003
529 LEUKOCYTOSIS 5 0.0003
530 TOOTHACHE 5 0.0003
531 HYPOKINESIA 4 0.0003
532 INTERVERTEBRAL DISC PROTRUSION 6 0.0003
533 OSTEONECROSIS 9 0.0003
534 WOUND INFECTION 3 0.0003
535 PARAESTHESIA 43 0.0003
536 TOOTH FRACTURE 3 0.0003
537 BLINDNESS TRANSIENT 2 0.0003
538 FOOT DEFORMITY 3 0.0003
539 CEREBRAL DISORDER 2 0.0003
540 ARTHROPOD BITE 2 0.0003
541 MEDICATION ERROR 15 0.0003
542 PULMONARY MASS 4 0.0003
543 ANHEDONIA 7 0.0003
544 SCAB 3 0.0003
545 CHOLECYSTECTOMY 3 0.0003
546 WITHDRAWAL SYNDROME 11 0.0003
547 HIP ARTHROPLASTY 4 0.0003
548 SHOCK 6 0.0003
549 WHITE BLOOD CELL COUNT INCREASED 10 0.0003
550 JAUNDICE 7 0.0003
551 CONGENITAL ANOMALY 2 0.0003
552 ELECTROLYTE IMBALANCE 3 0.0003
553 DYSTONIA 5 0.0003
554 MUSCULAR WEAKNESS 29 0.0003
555 AFFECTIVE DISORDER 2 0.0003
556 DISABILITY 5 0.0003
557 DEPRESSED LEVEL OF CONSCIOUSNESS 10 0.0003
558 COMA 12 0.0003
559 HYPERLIPIDAEMIA 3 0.0003
560 MUSCLE RIGIDITY 3 0.0003
561 ATRIAL FLUTTER 2 0.0003
562 NECK PAIN 14 0.0003
563 SPEECH DISORDER 13 0.0002
564 LIVER DISORDER 11 0.0002
565 EMOTIONAL DISTRESS 30 0.0002
566 RESPIRATORY FAILURE 18 0.0002
567 DYSKINESIA 10 0.0002
568 POST PROCEDURAL INFECTION 2 0.0002
569 RESTLESSNESS 9 0.0002
570 HICCUPS 2 0.0002
571 OSTEONECROSIS OF JAW 6 0.0002
572 SPINAL COMPRESSION FRACTURE 2 0.0002
573 PHARYNGITIS 3 0.0002
574 CYST 3 0.0002
575 MUSCLE INJURY 2 0.0002
576 TOOTH LOSS 5 0.0002
577 COAGULOPATHY 4 0.0002
578 UNEVALUABLE EVENT 18 0.0002
579 PSYCHOTIC DISORDER 7 0.0002
580 HEPATITIS 6 0.0002
581 IMPAIRED WORK ABILITY 5 0.0002
582 MYDRIASIS 3 0.0002
583 APHASIA 7 0.0002
584 JOINT STIFFNESS 6 0.0002
585 NAIL DISORDER 2 0.0002
586 BURNING SENSATION 16 0.0002
587 RESPIRATORY RATE INCREASED 2 0.0002
588 EYE HAEMORRHAGE 3 0.0002
589 FACIAL PAIN 2 0.0002
590 PULMONARY OEDEMA 10 0.0002
591 CHROMATURIA 5 0.0002
592 LIMB INJURY 6 0.0002
593 BONE DISORDER 4 0.0002
594 RETINAL DETACHMENT 2 0.0002
595 BLOOD THYROID STIMULATING HORMONE INCREASED 2 0.0002
596 MUSCLE TWITCHING 5 0.0002
597 PERICARDIAL EFFUSION 5 0.0002
598 ROAD TRAFFIC ACCIDENT 9 0.0002
599 BLOOD TEST ABNORMAL 3 0.0002
600 DYSARTHRIA 8 0.0002
601 BLOOD URINE PRESENT 4 0.0002
602 NERVOUSNESS 11 0.0002
603 LOWER LIMB FRACTURE 4 0.0002
604 ACUTE RESPIRATORY FAILURE 4 0.0002
605 PRODUCT USE ISSUE 39 0.0002
606 TRANSIENT ISCHAEMIC ATTACK 7 0.0002
607 ASPARTATE AMINOTRANSFERASE INCREASED 11 0.0002
608 HEPATOMEGALY 2 0.0002
609 BLADDER DISORDER 2 0.0002
610 THERAPY NON-RESPONDER 9 0.0002
611 CYTOKINE RELEASE SYNDROME 4 0.0002
612 OSTEOPENIA 3 0.0002
613 FEEDING DISORDER 4 0.0002
614 SUBARACHNOID HAEMORRHAGE 2 0.0002
615 FEELING HOT 12 0.0002
616 NEUTROPHIL COUNT INCREASED 2 0.0002
617 OSTEOPOROSIS 8 0.0002
618 INJECTION SITE WARMTH 4 0.0002
619 MUSCULOSKELETAL STIFFNESS 17 0.0002
620 HYPERBILIRUBINAEMIA 2 0.0002
621 SWOLLEN TONGUE 6 0.0002
622 PRODUCT USE COMPLAINT 3 0.0002
623 BLOOD LACTATE DEHYDROGENASE INCREASED 3 0.0002
624 INCONTINENCE 2 0.0002
625 JOINT DISLOCATION 2 0.0002
626 PNEUMOTHORAX 3 0.0002
627 SUDDEN DEATH 2 0.0002
628 CLOSTRIDIUM DIFFICILE COLITIS 2 0.0002
629 OBESITY 3 0.0002
630 SCIATICA 3 0.0002
631 RETCHING 4 0.0002
632 ANXIETY 53 0.0002
633 FEAR 5 0.0002
634 SWELLING FACE 12 0.0002
635 SKIN LACERATION 2 0.0002
636 BACK INJURY 2 0.0002
637 PULMONARY THROMBOSIS 2 0.0002
638 OESOPHAGITIS 2 0.0002
639 CHOLELITHIASIS 6 0.0002
640 METASTASES TO BONE 3 0.0002
641 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 13 0.0002
642 ASPIRATION 2 0.0002
643 GENERALISED TONIC-CLONIC SEIZURE 3 0.0002
644 MENTAL STATUS CHANGES 5 0.0002
645 OBSTRUCTIVE AIRWAYS DISORDER 2 0.0002
646 FEELING COLD 5 0.0002
647 ALANINE AMINOTRANSFERASE INCREASED 11 0.0002
648 HYPERHIDROSIS 23 0.0002
649 FISTULA 2 0.0002
650 HEMIPARESIS 3 0.0002
651 DISORIENTATION 7 0.0002
652 PAIN IN JAW 5 0.0002
653 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 3 0.0002
654 SKIN DISCOLOURATION 8 0.0002
655 LETHARGY 10 0.0002
656 BALANCE DISORDER 15 0.0002
657 MULTI-ORGAN FAILURE 3 0.0002
658 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 9 0.0002
659 HYPERSENSITIVITY 32 0.0002
660 POST PROCEDURAL HAEMORRHAGE 2 0.0002
661 LYMPHOCYTE COUNT DECREASED 3 0.0002
662 INJECTION SITE SWELLING 13 0.0002
663 ACUTE MYOCARDIAL INFARCTION 5 0.0002
664 AMNESIA 11 0.0002
665 TREMOR 28 0.0002
666 MATERNAL EXPOSURE DURING PREGNANCY 15 0.0002
667 NEUROPATHY PERIPHERAL 16 0.0002
668 THIRST 3 0.0002
669 MYOCLONUS 2 0.0002
670 FLUSHING 17 0.0002
671 GAIT DISTURBANCE 32 0.0002
672 RESPIRATORY DISORDER 5 0.0002
673 DISTURBANCE IN ATTENTION 9 0.0002
674 PAIN IN EXTREMITY 49 0.0002
675 ARTHRITIS 13 0.0002
676 CORONARY ARTERY DISEASE 5 0.0002
677 RESTLESS LEGS SYNDROME 3 0.0002
678 PANIC ATTACK 6 0.0002
679 SEIZURE 19 0.0002
680 BLOOD PRESSURE INCREASED 25 0.0002
681 DRUG ADMINISTRATION ERROR 5 0.0002
682 GASTROOESOPHAGEAL REFLUX DISEASE 13 0.0002
683 BLOOD ALKALINE PHOSPHATASE INCREASED 4 0.0002
684 TUBULOINTERSTITIAL NEPHRITIS 3 0.0002
685 BONE DENSITY DECREASED 5 0.0002
686 PHOTOPHOBIA 3 0.0002
687 RENAL FAILURE 21 0.0002
688 PROTEINURIA 3 0.0002
689 INJECTION SITE IRRITATION 2 0.0002
690 CHEST DISCOMFORT 16 0.0002
691 OEDEMA PERIPHERAL 19 0.0002
692 GLAUCOMA 3 0.0002
693 ERYTHEMA 32 0.0002
694 ANOREXIA 2 0.0002
695 NIGHT SWEATS 5 0.0002
696 HERNIA 3 0.0002
697 INFLAMMATION 8 0.0002
698 HIATUS HERNIA 2 0.0002
699 EAR PAIN 3 0.0002
700 HAEMORRHOIDS 3 0.0002
701 ORAL HERPES 3 0.0002
702 CHILLS 18 0.0002
703 PLATELET COUNT INCREASED 2 0.0002
704 NODULE 2 0.0002
705 SEDATION 4 0.0002
706 INCORRECT DOSE ADMINISTERED BY DEVICE 4 0.0002
707 SEPSIS 17 0.0002
708 IMPAIRED HEALING 5 0.0002
709 ORAL CANDIDIASIS 2 0.0002
710 BACK PAIN 35 0.0002
711 EXPIRED PRODUCT ADMINISTERED 5 0.0002
712 BLOOD CHOLESTEROL INCREASED 7 0.0002
713 BLOOD BILIRUBIN INCREASED 4 0.0001
714 VERTIGO 9 0.0001
715 OEDEMA 8 0.0001
716 MUSCLE SPASMS 27 0.0001
717 PNEUMONITIS 4 0.0001
718 IMPAIRED GASTRIC EMPTYING 2 0.0001
719 PERIPHERAL COLDNESS 2 0.0001
720 CONTUSION 14 0.0001
721 DELIRIUM 5 0.0001
722 CARDIO-RESPIRATORY ARREST 6 0.0001
723 COORDINATION ABNORMAL 2 0.0001
724 HYPERKALAEMIA 5 0.0001
725 DEVICE OCCLUSION 2 0.0001
726 ARTHRALGIA 59 0.0001
727 BLINDNESS UNILATERAL 2 0.0001
728 LYMPHADENOPATHY 5 0.0001
729 HEPATOCELLULAR INJURY 2 0.0001
730 INTERNATIONAL NORMALISED RATIO INCREASED 4 0.0001
731 SYNCOPE 14 0.0001
732 RED BLOOD CELL COUNT DECREASED 4 0.0001
733 SOMNOLENCE 28 0.0001
734 PRURITUS GENERALISED 3 0.0001
735 PARAESTHESIA ORAL 2 0.0001
736 PULMONARY ARTERIAL HYPERTENSION 2 0.0001
737 FEELING ABNORMAL 33 0.0001
738 HYPERGLYCAEMIA 5 0.0001
739 PALPITATIONS 16 0.0001
740 ASCITES 4 0.0001
741 DYSURIA 5 0.0001
742 CARDIOMYOPATHY 2 0.0001
743 BRONCHITIS 10 0.0001
744 STEVENS-JOHNSON SYNDROME 3 0.0001
745 TRANSAMINASES INCREASED 3 0.0001
746 TOOTH DISORDER 3 0.0001
747 ORAL PAIN 3 0.0001
748 HEPATIC FUNCTION ABNORMAL 5 0.0001
749 ABDOMINAL PAIN 31 0.0001
750 BONE LOSS 2 0.0001
751 BLOOD POTASSIUM DECREASED 4 0.0001
752 PREMATURE BABY 4 0.0001
753 HEPATIC FAILURE 4 0.0001
754 JOINT SWELLING 16 0.0001
755 HYPERTENSION 28 0.0001
756 DEPRESSION 30 0.0001
757 DEVICE RELATED INFECTION 2 0.0001
758 OVERDOSE 28 0.0001
759 LIMB DISCOMFORT 4 0.0001
760 CONSTIPATION 28 0.0001
761 DIZZINESS 64 0.0001
762 INSOMNIA 34 0.0001
763 SLEEP DISORDER 9 0.0001
764 HALLUCINATION, AUDITORY 2 0.0001
765 MIGRAINE 12 0.0001
766 ACUTE KIDNEY INJURY 19 0.0001
767 LOCALISED INFECTION 3 0.0001
768 CONFUSIONAL STATE 20 0.0001
769 FALL 41 0.0001
770 CEREBRAL INFARCTION 3 0.0001
771 LIVER INJURY 3 0.0001
772 EYE DISORDER 4 0.0001
773 PYREXIA 42 0.0001
774 DYSGEUSIA 9 0.0001
775 EXTRAPYRAMIDAL DISORDER 3 0.0001
776 ANAEMIA 23 0.0001
777 PSYCHOMOTOR HYPERACTIVITY 2 0.0001
778 SKIN DISORDER 4 0.0001
779 HALLUCINATION 9 0.0001
780 SURGERY 7 0.0001
781 FACE OEDEMA 2 0.0001
782 DIABETES MELLITUS 9 0.0001
783 HYPOPHAGIA 3 0.0001
784 HEADACHE 73 0.0001
785 RECTAL HAEMORRHAGE 5 0.0001
786 HYPOACUSIS 5 0.0001
787 SKIN ULCER 3 0.0001
788 DYSPHAGIA 11 0.0001
789 ORTHOSTATIC HYPOTENSION 2 0.0001
790 DEAFNESS 3 0.0001
791 LOCAL SWELLING 2 0.0001
792 RASH MACULAR 4 0.0001
793 URTICARIA 19 0.0001
794 CHEST PAIN 21 0.0001
795 GENERAL PHYSICAL HEALTH DETERIORATION 13 0.0001
796 THROMBOSIS 9 0.0001
797 ELECTROCARDIOGRAM QT PROLONGED 4 0.0001
798 THROAT TIGHTNESS 3 0.0001
799 NO ADVERSE EVENT 20 0.0001
800 PELVIC PAIN 2 0.0001
801 TREATMENT NONCOMPLIANCE 6 0.0001
802 SKIN LESION 3 0.0001
803 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 6 0.0001
804 AGITATION 8 0.0001
805 TREATMENT FAILURE 9 0.0001
806 OFF LABEL USE 94 0.0001
807 WOUND 3 0.0001
808 BLOOD CREATININE INCREASED 7 0.0001
809 BACTERIAL INFECTION 2 0.0001
810 RENAL IMPAIRMENT 9 0.0001
811 HEPATIC CIRRHOSIS 2 0.0001
812 VOMITING 50 0.0001
813 BLOOD SODIUM DECREASED 2 0.0001
814 HYPOCALCAEMIA 2 0.0001
815 FOOT FRACTURE 2 0.0001
816 PRODUCTIVE COUGH 5 0.0001
817 PULMONARY FIBROSIS 2 0.0001
818 CHOLESTASIS 2 0.0001
819 ASTHENIA 39 0.0001
820 INFECTION 15 0.0001
821 LIVER FUNCTION TEST ABNORMAL 3 0.0001
822 BLOOD PRESSURE SYSTOLIC INCREASED 2 0.0001
823 CHOKING 2 0.0001
824 DYSPNOEA 58 0.0001
825 MENORRHAGIA 2 0.0001
826 NAUSEA 80 0.0001
827 HEART RATE INCREASED 10 0.0001
828 DRY EYE 5 0.0001
829 PREGNANCY 2 0.0001
830 EXTRA DOSE ADMINISTERED 4 0.0001
831 PLEURAL EFFUSION 6 0.0001
832 MOBILITY DECREASED 7 0.0001
833 RIB FRACTURE 2 0.0001
834 PRURITUS 37 0.0001
835 POLLAKIURIA 4 0.0001
836 INTENTIONAL DRUG MISUSE 2 0.0001
837 DERMATITIS 2 0.0001
838 PANCREATITIS 5 0.0001
839 RENAL FAILURE ACUTE 4 0.0001
840 HYPOTHYROIDISM 3 0.0001
841 METABOLIC ACIDOSIS 3 0.0001
842 URINARY TRACT INFECTION 16 0.0001
843 LIVER FUNCTION TEST INCREASED 2 0.0001
844 DEVICE LEAKAGE 4 0.0001
845 FAECES DISCOLOURED 2 0.0001
846 DEVICE DISLOCATION 4 0.0001
847 SEPTIC SHOCK 4 0.0001
848 MENTAL DISORDER 4 0.0001
849 PRODUCT DISPENSING ERROR 2 0.0001
850 RASH 40 0.0001
851 MELAENA 2 0.0001
852 VISUAL ACUITY REDUCED 3 0.0001
853 GAMMA-GLUTAMYLTRANSFERASE INCREASED 2 0.0001
854 FUNGAL INFECTION 3 0.0001
855 DEVICE ISSUE 8 0.0001
856 THROAT IRRITATION 4 0.0001
857 PANCREATITIS ACUTE 2 0.0001
858 VISUAL IMPAIRMENT 11 0.0001
859 ANGER 3 0.0001
860 EYE PAIN 5 0.0001
861 HEART RATE IRREGULAR 2 0.0001
862 SINUSITIS 9 0.0001
863 HAEMATURIA 3 0.0001
864 HYPOKALAEMIA 4 0.0001
865 COUGH 24 0.0001
866 DEVICE MALFUNCTION 6 0.0001
867 BONE PAIN 5 0.0001
868 WHEEZING 5 0.0001
869 DISEASE RECURRENCE 4 0.0001
870 BLOOD PRESSURE FLUCTUATION 2 0.0001
871 BLOOD GLUCOSE DECREASED 4 0.0001
872 IRRITABILITY 5 0.0001
873 TOXICITY TO VARIOUS AGENTS 14 0.0001
874 INTERSTITIAL LUNG DISEASE 4 0.0001
875 WRONG TECHNIQUE IN DRUG USAGE PROCESS 3 0.0001
876 MENTAL IMPAIRMENT 2 0.0001
877 C-REACTIVE PROTEIN INCREASED 3 0.0001
878 MYALGIA 14 0.0001
879 UNDERDOSE 6 0.0001
880 ATRIAL FIBRILLATION 8 0.0001
881 ENCEPHALOPATHY 2 0.0001
882 PNEUMONIA ASPIRATION 2 0.0001
883 INTENTIONAL PRODUCT USE ISSUE 7 0.0001
884 DYSPNOEA EXERTIONAL 3 0.0001
885 HOT FLUSH 6 0.0001
886 HAEMOGLOBIN DECREASED 8 0.0001
887 HAEMATOMA 2 0.0001
888 RESPIRATORY TRACT INFECTION 2 0.0001
889 ABDOMINAL DISTENSION 8 0.0001
890 APPLICATION SITE ERYTHEMA 2 0.0001
891 GASTRITIS 2 0.0001
892 CONDITION AGGRAVATED 23 0.0001
893 CARDIAC FAILURE 6 0.0001
894 CARDIAC FAILURE CONGESTIVE 6 0.0001
895 PNEUMONIA 24 0.0001
896 DRY MOUTH 6 0.0001
897 PALLOR 2 0.0001
898 INFLUENZA LIKE ILLNESS 6 0.0001
899 VISION BLURRED 10 0.0001
900 INJECTION SITE REACTION 5 0.0001
901 HAEMATOCHEZIA 4 0.0001
902 INJECTION SITE PAIN 22 0.0001
903 PANCYTOPENIA 4 0.0001
904 CEREBROVASCULAR ACCIDENT 12 0.0001
905 ANGINA PECTORIS 2 0.0001
906 EYE IRRITATION 4 0.0001
907 VAGINAL HAEMORRHAGE 3 0.0001
908 BLOOD GLUCOSE INCREASED 13 0.0001
909 MYOCARDIAL INFARCTION 12 0.0001
910 THERAPEUTIC RESPONSE UNEXPECTED 3 0.0001
911 ADVERSE DRUG REACTION 6 0.0001
912 THERAPEUTIC RESPONSE DECREASED 4 0.0001
913 SUICIDE ATTEMPT 4 0.0001
914 STOMATITIS 4 0.0001
915 EPILEPSY 2 0.0001
916 UPPER RESPIRATORY TRACT INFECTION 3 0.0001
917 PERIPHERAL SWELLING 10 0.0001
918 OROPHARYNGEAL PAIN 6 0.0001
919 FEMUR FRACTURE 2 0.0001
920 INJECTION SITE ERYTHEMA 8 0.0001
921 WEIGHT DECREASED 18 0.0001
922 RENAL DISORDER 3 0.0001
923 CARDIAC DISORDER 6 0.0001
924 MALAISE 28 0.0001
925 DRUG-INDUCED LIVER INJURY 2 0.0001
926 ARRHYTHMIA 3 0.0001
927 CYSTITIS 2 0.0001
928 RASH ERYTHEMATOUS 3 0.0001
929 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 3 0.0001
930 HIP FRACTURE 2 0.0001
931 HYPOGLYCAEMIA 3 0.0001
932 ALOPECIA 12 0.0001
933 DYSPEPSIA 6 0.0001
934 LIP SWELLING 2 0.0001
935 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 2 0.0001
936 MEMORY IMPAIRMENT 8 0.0001
937 FATIGUE 45 0.0001
938 DRUG INTERACTION 9 0.0001
939 CRYING 2 0.0001
940 SUICIDAL IDEATION 5 0.0001
941 ABDOMINAL PAIN UPPER 11 0.0001
942 HYPONATRAEMIA 3 0.0001
943 ASTHMA 6 0.0001
944 COLITIS 2 0.0001
945 DYSPHONIA 3 0.0001
946 DIARRHOEA 33 0.0001
947 NASAL CONGESTION 3 0.0001
948 CATARACT 3 0.0001
949 NASOPHARYNGITIS 9 0.0000
950 MALIGNANT NEOPLASM PROGRESSION 5 0.0000
951 DRUG ABUSE 4 0.0000
952 HAEMORRHAGE 5 0.0000
953 ANGIOEDEMA 2 0.0000
954 DEHYDRATION 6 0.0000
955 WEIGHT INCREASED 10 0.0000
956 HEPATIC ENZYME INCREASED 3 0.0000
957 LOWER RESPIRATORY TRACT INFECTION 2 0.0000
958 COGNITIVE DISORDER 2 0.0000
959 DRUG DOSE OMISSION 7 0.0000
960 ABDOMINAL DISCOMFORT 7 0.0000
961 EPISTAXIS 3 0.0000
962 AGGRESSION 2 0.0000
963 ACNE 3 0.0000
964 DECREASED APPETITE 9 0.0000
965 PLATELET COUNT DECREASED 4 0.0000
966 DRUG DEPENDENCE 6 0.0000
967 RASH PRURITIC 2 0.0000
968 GASTROINTESTINAL DISORDER 3 0.0000
969 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 6 0.0000
970 ADVERSE EVENT 3 0.0000
971 HOSPITALISATION 5 0.0000
972 PRODUCT USE IN UNAPPROVED INDICATION 8 0.0000
973 RHINORRHOEA 2 0.0000
974 FEBRILE NEUTROPENIA 2 0.0000
975 DRY SKIN 4 0.0000
976 NEUTROPENIA 4 0.0000
977 COVID-19 5 0.0000
978 SKIN BURNING SENSATION 2 0.0000
979 WHITE BLOOD CELL COUNT DECREASED 3 0.0000
980 THROMBOCYTOPENIA 3 0.0000
981 RHEUMATOID ARTHRITIS 3 0.0000
982 INJECTION SITE BRUISING 2 0.0000
983 FOETAL EXPOSURE DURING PREGNANCY 2 0.0000
984 GASTROINTESTINAL HAEMORRHAGE 2 0.0000
985 SKIN EXFOLIATION 2 0.0000
986 INTENTIONAL PRODUCT MISUSE 2 0.0000
987 BREAST CANCER 2 0.0000
988 DEATH 17 0.0000
989 ACCIDENTAL EXPOSURE TO PRODUCT 2 0.0000
990 INFLUENZA 2 0.0000
991 INCORRECT DOSE ADMINISTERED 4 0.0000
992 PRODUCT DOSE OMISSION ISSUE 3 0.0000